Skip to content

The effect of motor control training on patients with patellofemoral pain:An interventional study and exploration of underlying central mechanisms

The effect of motor control training on patients with patellofemoral pain:An interventional study and exploration of underlying central mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105877
Enrollment
Unknown
Registered
2025-07-14
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellofemoral Pain

Interventions

Motor control training group:Six weeks of motor control training, including a training program for lower limb alignment adjustment.
Conventional strength training group:Six weeks of conventional strength training, including strength training for muscles around the knee and hip joints.

Sponsors

Beijing Sport University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 45 years old; 2. Presence of unilateral lower limb patellofemoral joint pain, determined by meeting all of the following criteria: (1) Peripatellar or anterior knee pain lasting =6 weeks, with a baseline VAS score for patellofemoral pain >=3; (2) Pain experienced during at least two of the following functional activities: prolonged sitting with bent knees, stair climbing (ascending or descending), squatting, kneeling, running, or jumping; (3) Positive patellar grind test or tenderness upon palpation of the medial or lateral patellar facet; 3. Willingness to refrain from receiving any treatment for patellofemoral pain other than the study intervention during the course of the study.

Exclusion criteria

Exclusion criteria: 1. History of knee joint surgery, or presence of patellar tendinitis, patellar dislocation, ligament injury, meniscal damage, or neurological disorders affecting the knee joint; 2. Concomitant acute joint injuries, such as acute sprains, ligament tears, persistent edema, severe open wounds, or fractures; 3. Co-existing severe systemic diseases that may affect joint mobility and function, including but not limited to severe hepatic, renal, cardiovascular, or cerebrovascular diseases, malignancies, severe intervertebral disc or vertebral body lesions, and osteoporosis; 4. Conditions that may affect muscle strength, such as diabetes mellitus, rheumatoid arthritis, or other neuromuscular disorders; 5. Recent (within a short period prior to study participation) use of topical or oral corticosteroids or other anti-inflammatory medications; 6. Inability or unwillingness to tolerate functional near-infrared spectroscopy (fNIRS) brain imaging procedures.

Design outcomes

Primary

MeasureTime frame
Anterior Knee Pain Scale,AKPS;VAS;KOOS-PF;Muscle activation( surface EMG);

Secondary

MeasureTime frame
Muscle stiffness;Lower limb kinematic and dynamic;Cerebral hemodynamics, fNIRS;

Countries

China

Contacts

Public ContactYuqing Jia

Beijing Sport University

JIAYQ1028@163.com+86 131 3323 4013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026